These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18384523)

  • 1. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.
    Pocobelli G; Cook LS; Brant R; Lee SS
    Liver Int; 2008 Nov; 28(9):1272-9. PubMed ID: 18384523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976-2005.
    Lee LT; Huang HY; Huang KC; Chen CY; Lee WC
    Ann Epidemiol; 2009 May; 19(5):323-8. PubMed ID: 19362276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001.
    Shibuya K; Yano E
    Int J Epidemiol; 2005 Apr; 34(2):397-402. PubMed ID: 15561746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.
    Liu S; Semenciw R; Ugnat AM; Mao Y
    Br J Cancer; 2001 Nov; 85(9):1335-9. PubMed ID: 11720471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis.
    Liu S; Semenciw R; Mao Y
    Hematol Oncol; 2003 Jun; 21(2):57-66. PubMed ID: 12802810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
    Shea KA; Fleming LE; Wilkinson JD; Wohler-Torres B; McKinnon JA
    Cancer; 2001 Mar; 91(5):1046-51. PubMed ID: 11251958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
    Nguyen VT; Amin J; Law MG; Dore GJ
    J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An age-period-cohort modelling study on primary liver cancer incidence rate in Qidong].
    Shen QJ; Zhang XF; Chen JG; Li WG; Yao HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):902-4. PubMed ID: 15631754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review.
    Cortes-Espinosa T; Mondragón-Sánchez R; Hurtado-Andrade H; Sánchez-Cisneros R
    Hepatogastroenterology; 1997; 44(17):1401-3. PubMed ID: 9356862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
    Roberts SK; Kemp W
    J Gastroenterol Hepatol; 2007 Feb; 22(2):191-6. PubMed ID: 17295870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience.
    Jan CF; Chen CJ; Chen HH
    J Gastroenterol Hepatol; 2005 Apr; 20(4):521-6. PubMed ID: 15836699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence and decreasing mortality of colorectal cancer due to marked cohort effects in southern Netherlands.
    van Steenbergen LN; Lemmens VE; Louwman MJ; Straathof JW; Coebergh JW
    Eur J Cancer Prev; 2009 Apr; 18(2):145-52. PubMed ID: 19337062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in the incidence of hepatocellular carcinoma in liver cirrhosis. A retrospective necropsy study in a large Romanian town (1973-1992).
    Acalovschi M; Pascu M; Iobagiu S; Ban A; Olinici DC; Petrescu M
    Rom J Intern Med; 1996; 34(1-2):85-90. PubMed ID: 8908635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].
    Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H
    Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the future epidemiological situation of tuberculosis in Japan].
    Ohmori M; Yoshiyama T; Ishikawa N
    Kekkaku; 2008 Apr; 83(4):365-77. PubMed ID: 18516900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing incidence of hepatocellular carcinoma in Japan.
    Okuda K; Fujimoto I; Hanai A; Urano Y
    Cancer Res; 1987 Sep; 47(18):4967-72. PubMed ID: 3040235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.